46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
May 31, 2026
|
15:30
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
...
Full Story at Source
Related News
Ukraine boosts its defenses near Belarus amid concerns the Russian ally will join the war
Man Utd kid Tyler Fletcher's remarkable Scotland World Cup call
CPKC to maintain rail operations across Canada during IBEW strike
Here's how Gap's yoga-wear maker Athleta went from must-have to 'generic'
